A Randomized, Double-blind, Double-dummy, Multicenter Parallel Group Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil Versus Vardenafil PRN Versus Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving Erectile Function.
Phase of Trial: Phase III
Latest Information Update: 03 Jul 2014
At a glance
- Drugs Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Acronyms REINVENT
- Sponsors Bayer
- 07 Jul 2009 Bayer HealthCare Pharmaceuticals Company added as trial affiliate as reported by ClinicalTrials.gov.
- 01 Oct 2008 Primary endpoint 'Erectile clinical response' has been met.
- 19 Aug 2008 Status changed from in progress to completed according to a Bayer media release.